A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Table 4 Extrapolated results for an intake of 1,000 mg/day of EPA or DHA

All data included		EPA		DHA
TRT	Statistic	%∆	Extrapolated % ∆	%∆	Extrapolated % ∆
rTG	Mean	151	232	45	99
rTG	SD	103	158	36	81
EE	Mean	155	205	13	57
EE	SD	124	164	32	139
PL	Mean	35	232	9	99
PL	SD	45	303	20	223
TG	Mean	36	198	19	86
TG	SD	43	241	27	124
Negative data deleted*		EPA		DHA
TRT	Statistic	%∆	Extrapolated % ∆	%∆	Extrapolated % ∆
rTG	Mean	151	232	45	99
rTG	SD	103	158	36	81
EE	Mean	155	205	26	113
EE	SD	124	164	32	141
PL	Mean	53	354	22	240
PL	SD	36	242	16	180
TG	Mean	50	278	27	123
TG	SD	33	185	25	115
Negative data allocated 0 value**		EPA		DHA
TRT	Statistic	%∆	Extrapolated % ∆	%∆	Extrapolated % ∆
rTG	Mean	151	232	45	99
rTG	SD	103	158	36	81
EE	Mean	155	205	17	74
EE	SD	124	164	29	125
PL	Mean	40	266	13	142
PL	SD	39	260	16	182
TG	Mean	41	226	21	96
TG	SD	36	200	25	113

*Any subject data in which the EPA or DHA values decreased from Day 0 to Day 28 were deleted from the extrapolation calculations for the appropriate omega-3 fatty acid.
**Any subject data in which the EPA and/or DHA values decreased from Day 0 to Day 28 were given a value of zero (0) for the omega-3 fatty acid(s) in question.

ISSN: 1476-511X